NOVACYT REVENUES HALF YEAR 2017 Consolidated sales growth +53% CER Group continues positive outlook for 2017

Novacyt revenues half year 2017 ENGLISH Paris, France and Cambridge, UK – 20th July 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces its unaudited revenues for the six months ended 30 June 2017 (the “Period”).

Visit Page

NOVACYT FULL YEAR 2016 RESULTS DELIVER DOUBLE DIGIT SALES GROWTH Strong start to 2017 accelerating trajectory towards profitability

Novacyt FY16 financial results PR ENG Paris, France and Cambridge, UK – 27 April 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its financial results for the year ended 31 December 2016.

Visit Page